Home
Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 10/02
Trade details
- Type
- Insider sale
- Amount
- $775,165.03
- Shares · price
- 1,346 sh · $575.90 a share
- Held after
- 329,313 sh
- Trade date
- 26/10/01
- Filed
- 26/10/02
- Days to filing
- 1 days
Sold 0.4% of holdings
- Share of holding sold
- 0.4%
United Therapeutics trades, last 26 weeks
What else happened in United Therapeutics around then
Filed or reported within 30 days of the trade day · 09/01~10/31Martine A. Rothblatt's recent trades
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$537.5K
930 sh
$537.5K
Filed 10/02
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$501.3K
864 sh
$501.3K
Filed 10/02
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$477.2K
830 sh
$477.2K
Filed 10/02
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$446.5K
774 sh
$446.5K
Filed 10/02
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$408K
702 sh
$408K
Filed 10/02
Traded 10/01